Selecta Biosciences, Inc. Profile Avatar - Palmy Investing

Selecta Biosciences, Inc.

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program …

Biotechnology
US, Watertown [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Selecta Biosciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of SELB's Analysis
CIK: 1453687 CUSIP: 816212104 ISIN: US8162121045 LEI: - UEI: -
Secondary Listings
SELB has no secondary listings inside our databases.